In the Boardroom
Refine Search
Biotechnology
US clinical-stage drug developer Acumen Pharmaceuticals has appointed Amy Schacterle as chief regulatory officer and head of quality, reporting to Jim Doherty, president and chief development officer at Acumen. 7 November 2024
Biotechnology
Memo Therapeutics, a privately-held Swiss biotech company translating unique responses into superior medicines to treat viral infections and cancer, has appointed a new chief development officer (CDO). 4 November 2024
Biotechnology
Netherlands-based Tessellate BIO, a pre-clinical stage biotech with a focus on novel synthetic lethality approaches, today announced the appointment of Dr Lara Boyd as chief business officer. 4 November 2024
Biotechnology
US biotech major Biogen revealed it has appointed Daniel Quirk as chief medical officer and head of medical affairs. 29 October 2024
Pharmaceutical
Fennec Pharmaceuticals has announced the addition of three new executives to bolster its leadership team as the company prepares for expanded commercial operations. 28 October 2024
Biotechnology
AAVantgarde has announced the appointment of Lauren Kaskiel as chief business officer (CBO). 22 October 2024
Pharmaceutical
British artificial intelligence specialist BenevolentAI has announced the return of its founder, Ken Mulvany, as executive chairman. 18 October 2024
Biotechnology
Denmark’s Commit Biologics, a specialist in the activation of the complement system to treat cancer and autoimmune disease, has announced the appointment of Mikkel Wandahl Pedersen as chief scientific officer (CSO). 15 October 2024
Pharmaceutical
Canada-based biotech Sernova (TSX: SVA) has announced key new appointments to its executive leadership team. 15 October 2024
Biotechnology
French biotech Innate Pharma has appointed Jonathan Dickinson as its new chief executive (CEO) and chairman of the executive board, effective November 1, 2024. 14 October 2024
Biotechnology
Turnstone Biologics has announced a major restructuring of its operations, cutting its workforce by approximately 60%. 14 October 2024
Pharmaceutical
Cancer start-up Black Diamond Therapeutics has announced a significant restructuring as part of its plan to focus resources on its lead drug, BDTX-1535. 10 October 2024
Biotechnology
Calluna Pharma, a biotech focused on treating inflammatory and fibrotic diseases, has appointed Mark Gaffney as its new chief executive. 9 October 2024
Biotechnology
Privately-held UK biotech Curve Therapeutics has announced the appointment of Rab Prinjha as chief research and development (R&D) officer. 9 October 2024
Biotechnology
French cancer vaccine focused biotech Oncovita has appointed Dr Stéphane Altaba as its new chief executive (CEO). 9 October 2024
Biotechnology
Cambridge, USA-based biotech Judo Bio has announced the company’s launch and $100 million in initial financing, including seed financing and Series A. 7 October 2024
Biotechnology
Mosaic Therapeutics, a UK-based oncology therapeutics company dedicated to resolving cancer’s complexity to power new combination therapies for patients, has announced the appointment of Barry Davies as chief scientific officer. 7 October 2024
Pharmaceutical
US pharma giant Pfizer (NYSE: PFE) has announced that John McGinley has been appointed UK managing director and country president. 7 October 2024
Pharmaceutical
ViroCell Biologics, a UK contract development and manufacturing organization (CDMO), has announces the appointment of Nicholas Ostrout, as vice president of corporate development and strategy. 7 October 2024
Biotechnology
Following a boardroom shake up last month by its new chief executive Ludwig Hantson, US biotech firm Alexion Pharmaceuticals yesterday announced that Paul Clancy, a seasoned financial executive with 30 years of experience, will join the company on July 10, 2017 and will assume the role of chief financial officer (CFO) effective July 31, 2017. 14 June 2017
Pharmaceutical
In a battle which commentators might observe embodies a wider conflict of its time, the row engulfing Netherlands-incorporated drugmaker Mylan has entered another ugly round. 13 June 2017
Biotechnology
Belgian biotech drug developer Ablynx has replaced its chief business officer, appointing Markus Ewert to lead the company’s business development and corporate strategy. 13 June 2017
Pharmaceutical
Mylan is fighting battles on multiple fronts, including over price increases of its EpiPen (epinephrine) devices and as it races to market with its biosimilar products. 7 June 2017
Generics
Just 14 months after taking the reins at Perrigo, John Hendrickson is to retire from his position as chief executive at the Ireland-incorporated generics drugmaker. 6 June 2017
Biotechnology
Dutch human gene therapy specialist uniQure (Nasdaq: QURE) has named Steven Zelenkofske as chief medical officer, effective immediately. 6 June 2017
Biotechnology
The American arm of the independent Swiss biotech company Octapharma has appointed Richard Walters as its new vice president of commercial development. 5 June 2017
Biotechnology
David Stamler has joined Australia’s Prana Biotechnology as chief medical officer and senior vice president, clinical development, based in San Francisco. 5 June 2017
Pharmaceutical
Privately-held Swiss firm Ferring Pharmaceuticals today announced that Paul Navarre has been appointed chief executive of Ferring Holding Inc. 2 June 2017
Biotechnology
Silence Therapeutics has recruited Torsten Hoffmann as chief operating officer, reporting directly to Ali Mortazavi, chief executive. This is not a plc board appointment. 1 June 2017
Biotechnology
A cloud is hanging over UK-registered biotech Akari Therapeutics after inaccuracies came to light in a trial comparing its lead product to a rival drug and questions arose over the role of its chief executive in a related report. 31 May 2017
Biotechnology
Ireland-incorporated biotech firm Alkermes has named Craig Hopkinson to the posts of chief medical officer, and senior vice president of clinical development and medical affairs. 31 May 2017
Biotechnology
Private biotech firm Constellation Pharmaceuticals has appointed Jigar Raythatha as president and chief executive officer. 25 May 2017
Biotechnology
Shares in US biotech firm Alexion Pharmaceuticals slumped nearly 10% today as investors were unsettled by a raft of management changes from new chief executive Ludwig Hantson. 24 May 2017
Biotechnology
British biotech firm Summit Pharmaceuticals has made several key appointments in its research and development unit. 23 May 2017
Pharmaceutical
Sweden-based specialty pharma company Pharmalink has announced the appointment of Renee Aguiar-Lucander as its new chief executive. 18 May 2017
Biotechnology
Actelion has detailed changes to its management team that will come into effect once the Swiss biotech firm becomes part of Johnson & Johnson. 16 May 2017
Pharmaceutical
UK-based GW Pharmaceuticals has appointed Volker Knappertz as chief medical officer (CMO). 15 May 2017
Pharmaceutical
Germany’s Merck KGaA has appointed Constantin Birnstiel as head of group communications. 12 May 2017
Pharmaceutical
Japan’s Astellas Pharma has promoted Shontelle Dodson to senior vice president and head of medical affairs Americas, effective May 15, 2017. Ms Dodson previously served as vice president of medical excellence within the global medical affairs organization. 12 May 2017
Sign up to receive email updates
Join industry leaders for a daily roundup of biotech & pharma news
Today's issue
Company Spotlight
A US biotech company dedicated to creating oral drugs with an emphasis on indications in virology and immunology.
Copyright © The Pharma Letter 2024 | Headless Content Management with Blaze